ABSTRACT
Adenocarcinoma of the prostate is currently the most common malignancy in men in the U.S., comprising 29% of all cancers. This year an estimated 232,090 men will be newly diagnosed with prostate cancer.
Adenocarcinoma of the prostate is currently the most common malignancy in men in the U.S., comprising 29% of all cancers. This year an estimated 232,090 men will be newly diagnosed with prostate cancer.